200 related articles for article (PubMed ID: 9688360)
1. Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans.
Aasmundstad TA; Størset P
Hum Exp Toxicol; 1998 Jun; 17(6):347-52. PubMed ID: 9688360
[TBL] [Abstract][Full Text] [Related]
2. Morphine glucuronidation increases its analgesic effect in guinea pigs.
Oliveira A; Pinho D; Albino-Teixeira A; Medeiros R; Dinis-Oliveira RJ; Carvalho F
Life Sci; 2014 Jul; 109(2):104-10. PubMed ID: 24968302
[TBL] [Abstract][Full Text] [Related]
3. Morphine metabolites.
Christrup LL
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
[TBL] [Abstract][Full Text] [Related]
4. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.
Wolff T; Samuelsson H; Hedner T
Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139
[TBL] [Abstract][Full Text] [Related]
5. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
Du X; Skopp G; Aderjan R
Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
[TBL] [Abstract][Full Text] [Related]
6. High levels of morphine-6-glucuronide in street heroin addicts.
Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of morphine glucuronidation in the 3- and 6-position by ranitidine in isolated hepatocytes from guinea pig.
Aasmundstad TA; Mørland J
Pharmacol Toxicol; 1998 Jun; 82(6):272-9. PubMed ID: 9677618
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
[TBL] [Abstract][Full Text] [Related]
9. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
12. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
Hasselström J; Säwe J
Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
14. Quantification of morphine and its major metabolites M3G and M6G in antemortem and postmortem samples.
Oliveira A; Carvalho F; Pinho PG; Remião F; Medeiros R; Dinis-Oliveira RJ
Biomed Chromatogr; 2014 Sep; 28(9):1263-70. PubMed ID: 25237710
[TBL] [Abstract][Full Text] [Related]
15. Relationships among morphine metabolism, pain and side effects during long-term treatment: an update.
Andersen G; Christrup L; Sjøgren P
J Pain Symptom Manage; 2003 Jan; 25(1):74-91. PubMed ID: 12565191
[TBL] [Abstract][Full Text] [Related]
16. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
Murthy BR; Pollack GM; Brouwer KL
J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
[TBL] [Abstract][Full Text] [Related]
17. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
[TBL] [Abstract][Full Text] [Related]
18. Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin.
Graziani M; Antonilli L; Togna AR; Brusadin V; Viola S; Togna G; Badiani A; Nencini P
Drug Alcohol Depend; 2008 Dec; 98(3):179-84. PubMed ID: 18597954
[TBL] [Abstract][Full Text] [Related]
19. Repeated exposures to heroin and/or cadmium alter the rate of formation of morphine glucuronides in the rat.
Antonilli L; Suriano C; Paolone G; Badiani A; Nencini P
J Pharmacol Exp Ther; 2003 Nov; 307(2):651-60. PubMed ID: 12975487
[TBL] [Abstract][Full Text] [Related]
20. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
